WGO Guidance for Patients with COVID-19 and liver disease

Drs. Cihan Yurdaydin, Past President and Chair of Nominations and Saeed Hamid, Chair of the WGO Hepatology Interest Group, in collaboration with members of the WGO Hepatology Interest Group, present general clinical guidelines for patients with COVID-19 and Liver Disease. Download and read it here!

Past President and Chair of Nominations
Prof. Cihan Yurdaydin
Istanbul,Turkey
Koc University Medical School
Dept. of Gastroenterology and Hepatology
cyurdaydin@ku.edu.tr

 

Chair, Hepatology Interest Group
Prof. Saeed Hamid
Karachi,Pakistan
Aga Khan University, Department of Medicine
saeed.hamid@aku.edu

 

 

Contributors* in alphabetical order:

MR Alvares da Silva, K Burak, T Chen, J Drenth, G Esmat, R Gaspar, D Labrecque, A Lee, G Macedo, B McMahon, Q Ning, N Reau, M Sonderup, DJ van Leeuwen ; Edited by S Hamid and C Yurdaydin

Accompanying Highlight Slides Sets

WGO Guidance for Patients with COVID-19 and liver disease

COVID-19 Infection in Persons with Underlying Chronic Viral Hepatitis - Brian J McMahon, MD (USA)

Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) and COVID- 19 - Menso Westerouen van Meeteren and Joost PH Drenth (Netherlands)

Management of Autoimmune Liver Disease During COVID-19 - Kelly W. Burak, MD, FRCPC, MSc (Epid) (Canada)

How to follow up patients with chronic liver diseases during the COVID-19 -pandemic? - Prof. Mario Reis Alvares-da-Silva (Brazil)

Performing Procedures in Chronic Liver Disease Patients – Prof. Guilherme Macedo, MD (Portugal)

Therapies under investigation for COVID-19 and potential hepatotoxicity - Gamal Esmat (Egypt)

Management of Hepatocellular Carcinoma (HCC) during Covid-19 - Douglas R. LaBrecque, (USA) and Mark Sonderup (South Africa)

Liver Transplantation and CoV-19 Infection, What will change? - Nancy Reau, MD